Operating Lease, Right-of-Use Asset of Fortress Biotech, Inc. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Fortress Biotech, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • Fortress Biotech, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $12,321,000, a 13% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Fortress Biotech, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $12,321,000 -$1,831,000 -13% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $12,817,000 -$1,809,000 -12% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $13,303,000 -$3,159,000 -19% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $13,861,000 -$3,129,000 -18% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 $14,152,000 -$3,355,000 -19% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $14,626,000 -$3,325,000 -19% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $16,462,000 -$3,005,000 -15% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $16,990,000 -$3,001,000 -15% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $17,507,000 -$2,249,000 -11% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $17,951,000 -$165,000 -0.91% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $19,467,000 +$902,000 +4.9% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $19,991,000 +$986,000 +5.2% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 $19,756,000 +$341,000 +1.8% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $18,116,000 -$1,615,000 -8.2% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $18,565,000 -$1,507,000 -7.5% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $19,005,000 -$1,482,000 -7.2% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $19,415,000 -$850,000 -4.2% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 $19,731,000 -$944,000 -4.6% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 $20,072,000 -$1,004,000 -4.8% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 $20,487,000 -$993,000 -4.6% 31 Dec 2020 10-K 28 Mar 2022 2021 FY
Q3 2020 $20,265,000 -$1,611,000 -7.4% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 $20,675,000 -$1,580,000 -7.1% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $21,076,000 -$1,542,000 -6.8% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 $21,480,000 +$21,480,000 31 Dec 2019 10-K/A 09 Apr 2021 2020 FY
Q3 2019 $21,876,000 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $22,255,000 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 $22,618,000 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 $0 31 Dec 2018 10-K 16 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.